trending Market Intelligence /marketintelligence/en/news-insights/trending/ti2ouvepwsri4vsgbufydw2 content esgSubNav
In This List

NantHealth director to forgo re-election

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


NantHealth director to forgo re-election

Mark Burnett does not plan to stand for re-election to the board of NantHealth Inc. at the company's next annual meeting of stockholders due to time constraints and other obligations.

Burnett will continue as a director until his term expires and will remain involved in other activities within the NantWorks LLC family of companies.

NantHealth said Burnett's decision to not stand for re-election was not the result of any disagreement on any matter relating to the company's operations, policies or practices.